Moneyta · stock research · no sign-up needed

Figures below come straight from SEC filings: every number is the company's own, on the record.

Revenue (Q2 FY2026)

$1M

+76.2% y/y

Net income (Q2 FY2026)

-$4M

as filed with the SEC

Institutions holding

Overview · Tenon Medical, Inc.

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the…

SectorHealthcare
IndustryMedical Devices
Typeequity
ExchangeNASDAQ
Employees22
www.tenonmed.com

Management team

Start your free trial to see the full management team.

Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.

What history says when its signals fire

Every signal Moneyta surfaces carries its full base-rate history: how often it beat the index, and how often it didn't. See the evidence

The desk's Snapshot

3 of 15 open to everyone · members see all
How sure is the desk?
Unlock with Silver
How fragile is the case?
Unlock with Silver
Did the read move?
Unlock with Silver
Did a risk fire?
Unlock with Silver
Who is accumulating?
Unlock with Gold
How is it trending?
Unlock with Silver
What would change the desk's mind?
Unlock with Silver

Read the full desk report on TNON

Seven analysts, the debate, the risk review, every claim cited. And the same for every name you hold.

7-day free trial. AI-written · every claim cites a source · Insight, not advice.

The full desk report

Seven AI analysts read the filings and argue both sides. What survives, with every claim cited, for members.

Start your free trial

Who holds it, who's buying Gold

Full holder table, quarter-over-quarter flows, insider transactions, and the conviction screen.

Largest holder

Net flow last quarter

Insider buys, 90d

See plans

Further reading

Source: SEC EDGAR (XBRL company facts, form 13F-HR). Educational analysis of published data — insight, not advice.

Now check the odds on your own portfolio

Paste your holdings and get a health score, concentration check, and plain-English observations in about a minute.

Start your 7-day free trial